(Q36973177)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18534821%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18534821%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

main subject

phase I clinical trial

0 references

0 references

1 reference

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18534821%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

4

Donald C Goff

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18534821%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

5

Henry A Nasrallah

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18534821%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

7

Gail L Daumit

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18534821%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

11

Jeffrey A Lieberman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18534821%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Jonathan M Meyer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18534821%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Vicki G Davis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18534821%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Joseph P McEvoy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18534821%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Sonia M Davis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18534821%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

John Hsiao

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18534821%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Marvin S Swartz

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18534821%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

language of work or name

English

0 references

publication date

4 June 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18534821%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

published in

Schizophrenia Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18534821%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18534821%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

1-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18534821%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

104-109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18534821%20AND%20SRC:MED&resulttype=core&format=json

Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1

8 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583138

Balancing efficacy and safety in treatment with antipsychotics.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583138

Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583138

Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583138

A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583138

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583138

The effects of antipsychotic therapy on serum lipids: a comprehensive review.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583138

A review of some statistical methods for covariance analysis of categorical data

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583138

Severe mental illness and risk of cardiovascular disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583138

Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583138

Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin Resistant

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583138

Relation of triglyceride levels, fasting and nonfasting, to fatal and nonfatal coronary heart disease

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583138

Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583138

Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women

4 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18534821

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Consensus development conference on antipsychotic drugs and obesity and diabetes

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18534821

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.SCHRES.2008.04.023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18534821%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18534821%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

PubMed publication ID

18534821

1 reference